Stock-Based Compensation

$11.19M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$11.19Mperiod endingJun 30, 2026

HRTX Stock-Based Comp ($0.00 → $11.19M)

Annual stock-based compensation

High-resolution chart · PNG

HRTX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	10,339,000
Dec 31, 2024	12,962,000
Dec 31, 2023	32,854,000
Dec 31, 2022	42,980,000
Dec 31, 2021	46,851,000
Dec 31, 2020	50,218,000
Dec 31, 2019	51,411,000
Dec 31, 2018	33,367,000
Dec 31, 2017	30,538,000
Dec 31, 2016	25,956,000
Dec 31, 2015	14,360,000
Dec 31, 2014	8,067,000
Dec 31, 2013	10,890,000
Dec 31, 2012	5,732,000
Dec 31, 2011	1,890,000
Dec 31, 2010	1,749,000
Dec 31, 2009	1,137,000
Dec 31, 2008	1,112,000
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0